babyÖ±²¥app

New Iridium, a company developing commercialized photocatalysis technologies to accelerate drug development and manufacturing, has been awarded a National Science Foundation (NSF) Small Business Technology Transfer (STTR) grant for $256,000 to conduct research and development work on facilitating timely availability of Remdesivir, a potential life-saving drug in the global fight against COVID-19.

This award will enable further research into the unique electromechanical failure mechanism in HASEL actuators, a new class of smart, soft, high-speed robotic hardware.

Researchers at CU Boulder, led by Professor Mike McGehee in the College of Engineering and Applied Science, have developed an improved method for controlling smart tinting on windows that could make them cheaper, more effective and more durable than current options on the market.

CU Boulder biomedical engineer Jacob Segil is working to bring back a sense of touch for amputees, including veterans of the wars in Iraq and Afghanistan.

CU Boulder researchers and the CU spinoff VitriVax Inc., are focused on finding a way to get vaccines to 7.8 billion people. The research team is able to do so with funding, licensing and startup support from Venture Partners at CU Boulder, the university’s commercialization arm.

Researchers are fast-tracking a new CU-born technology, SickStick, in hopes of not only helping to curb the current pandemic but also radically change the way we track disease in the future.

The next businesses to make a splash will come out of babyÖ±²¥app’s research institutions, including CU Boulder. Venture Partners' Managing Director Bryn Rees is featured in the article.

The company was cofounded in 2001 by professor Alan "Al" Weimer of chemical and biological engineering and professor Steven George of chemistry and biochemistry, along with CU alumni Mike Masterson and Karen Buechler. 

Venture Partners at CU Boulder is partnering with BridgeBio to advance novel drug discovery with an underlying genetic basis. Apply by Monday, March 16, 2020.

Vu, an assistant professor in the Department of Computer Science, is improving human cognitive functions using an ear-worn device. To bring the technology to customers worldwide later in 2020, he founded Earable Inc., which now has more than 15 employees.